Company: TAK
Filing Date: 2025-06-25
Form Type: 20-F
Source: 0001395064-25-000095
Chunk: 273

Company: TAKEDA PHARMACEUTICAL CO LTD
Filing Date: 2025-06-25
Form: 20-F
Item: Item 19
Chunk 273
---
 of JPY 61,024 71,510 73,585

Equity-settled Plans

Stock Options

Takeda previously provided a stock option plan under which it granted awards to members of Takeda’s board of directors (the “ Board”) and senior management through the year ended March 31, 2014. There were no three years 10 20

There was no compensation expense recorded during the years ended March 31, 2023, 2024 and 2025 as all awards were fully vested.

The following table summarizes the stock option activity:

                                   For the Year Ended March 31                                                                                 
                                   2023                                                                                                        
                                   Number of options                                                                                           
                                   (shares)                                                                                                    
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  As of beginning of the year                                       3,347,100      4,094       3,303,600      4,111      3,180,900      4,136  
  Exercised                                                         ( 43,500)      2,802      ( 122,700)      3,464      ( 12,000)      3,712  
  As of end of the year                                             3,303,600      4,111       3,180,900      4,136      3,168,900      4,138  

All of the stock options were exercisable as of March 31, 2023, 2024 and 2025.

The weighted-average share price at the date of exercise was JPY 3,852 4,540 4,167 4,111 9 4,136 8 4,138 7

Stock Incentive Plans

Takeda has the following 3 stock-based incentive compensation plans for its directors and eligible employees including members of senior management:

Board incentive plan (“ BIP”) Trust -The BIP Trust is an incentive plan for board directors designed based on Restricted Stock Units and Performance Share Units, whereby Restricted Stock Unit awards and Performance Share Unit awards are granted to board directors. Each award point is settled in a single share of the Company’s common stock. Under the BIP, Restricted Stock Unit awards are subject to certain service-based conditions, and vest ratably over three years three years three years three-year

Employee Stock Ownership Plan (“ ESOP”) Trust - The ESOP Trust is an